Impact Of COVID-19 Pandemic On Liquidity	12 Months Ended
Dec. 31, 2021
Impact Of COVID-19 Pandemic On Liquidity [Abstract]
Impact Of COVID-19 Pandemic On Liquidity	NOTE 3 – IMPACT OF COVID-19 PANDEMIC ON LIQUIDITY GeneralOn March 11, 2020, the World Health Organization (“WHO”) declared the novel coronavirus, COVID-19, a global pandemic. In March 2020 we temporarily closed all of our live theatres and cinema operations in the U.S., Australia and New Zealand. Operating restrictions adopted in Australia and New Zealand also affected many of our tenants at our retail shopping centers. These closures materially negatively impacted our revenues and profitability. Our cinemas began reopening at various times throughout the last quarter of 2020 and into 2021. COVID-19 has progressed through several variants, with the most current variant affecting the jurisdictions in which we do business being the Omicron variant. Vaccination programs are advancing, and it appears that societies are moving towards relaxing restrictions. There can be no assurances, however, that the current trend of reduced restrictions will continue, nor that there will be no further variants of COVID-19 which could lead to material business disruption. During 2020, we successfully implemented our COVID-19 response plans, generating cash inflows from strategic asset monetizations of $179.1 million and reducing or refinancing key debt. As a result of this, and the increasing health of the cinema segment, we have concluded that our Company has sufficient resources to meet its obligations as they become due within one year after the issuance of this Form 10-K. Cinema Segment Ongoing ImpactAs of December 31, 2021, none of our cinemas are closed as a result of COVID-19 government closure orders. As of the date of this report, substantially all of our U.S. cinemas are trading. On March 3, 2022, we reopened our Consolidated Theatre in Kapolei following a renovation. All of our New Zealand cinemas are trading except Courtenay Central which continues to be closed due to non-COVID related seismic concerns which predated the pandemic. A return to operation of this center has been delayed, however, by among other things our efforts to respond to COVID-19. Our Australian circuit is fully open. Real Estate Segment Ongoing ImpactSubstantially all of our tenants in our Australian and New Zealand real estate businesses (excluding Courtenay Central) are currently open for trading. In the U.S., much of our real estate income has traditionally been generated by rental revenue from our live theatres. As of the date of this report, our Minetta and Orpheum theatres are conducting public performances. Liquidity ImpactThe continued disruption of our global cinemas caused by COVID-19 led to a significant decrease in our Company’s revenues and earnings for the year ended December 31, 2021, as compared to pre-COVID-19 operations. Such effects will likely continue, to varying degrees, until the virus is materially contained and its impact on the cinema going public abates. As compared to the year ended December 31, 2020, our revenues and earnings have increased as we have been able to reopen, and keep open, many of our cinemas. Even though we are encouraged by the return of patrons to our cinemas and theatres and the movie releases expected in the coming months, we cannot provide any assurances as to the nature or pace of a return to prior operating levels. With regards to our real estate operations, while all our New Zealand and Australian real estate tenants are currently trading (other than certain tenants who have closed for reasons unrelated to COVID-19), our real estate revenue and earnings may again be affected by any rent relief that we may deem necessary to provide to certain tenants experiencing continuing impacts from COVID-19. Going ConcernWe continue to evaluate the going concern assertion required by ASC 205-40 Going Concern as it relates to our Company. Management’s evaluation is informed by current liquidity positions, cash flow estimates, known capital and other expenditure requirements and commitments and management’s current business plan and strategies. Our Company’s business plan - two businesses (real estate and cinema) in three countries (Australia, New Zealand and the U.S.) - has served us well since the onset of COVID-19 and is key to management’s overall evaluation of ASC 205-40 Going Concern. The cumulative impact of COVID-19 on our cinema business led to the conclusion in the third quarter of 2020 that there was substantial doubt regarding our Company’s ability to continue as a going concern; however, management’s plans to alleviate such substantial doubt included the adoption of plans to refinance our 44 Union Square property and the monetization of certain real estate assets. By June 2021 we had successfully executed these plans, as detailed in Note 5 – Real Estate Transactions and Note 11 – Borrowings. The execution of these plans generated cash inflows of $179.1 million. Furthermore, we have reduced our debt from $282.6 million at December 31, 2020 to $234.0 million at December 31, 2021. We have no debt maturing until March 2023, being our Bank of America facility as presented at Note 11 - Borrowings, and we have the funds to repay this debt in the event that our refinancing efforts are unsuccessful. There have been no material business developments in the period since the execution of our plans that have negatively impacted our assessment of our going concern position. We acknowledge the impact of the Omicron variant on the cinema industry, but its impact is proving to be less than those of past variants. We believe that our current cash holdings, and the current and expected future improvements in the cinema industry, are such that our going concern assessment has not changed since the execution of management’s plans. Our current financial position, forecasts and cash flow estimates based on our current expectations of industry performance and recovery, mean that our Company has sufficient resources to meet its obligations as they become due within one year after the issuance of this report on Form 10-K. Our forecasts and cash flow estimates are based on the current expectation that the global cinema industry will continue to recover in 2022 and 2023. Forecasts are by their nature inherently uncertain, but the effects of COVID-19 continue to cause greater forecasting difficulties than would otherwise exist in more stable economic times. While we are seeing substantial evidence of recovery, our forecasts rely upon the ability and desire of moviegoers to return to the movie theatres. Many factors influencing this are outside of management’s control, but are, nevertheless, material, individually and in the aggregate, to the realization of management’s forecasts and expectations throughout the period of COVID-19. Impairment Considerations Our Company considers that the events and factors described above continue to constitute impairment indicators under ASC 360 Property, Plant and Equipment. At December 31, 2021, our Company performed a quantitative recoverability test of the carrying values of all its asset groups. Our Company estimated the undiscounted future cash flows expected to result from the use of these asset groups and found that no impairment charge was necessary. This was due to our improved financial performance at the asset group level, and our more favorable expectations for future trading. Actual performance against our forecasts is dependent on several variables and conditions, many of which are subject to the uncertainties associated with COVID-19 and as a result, actual results may materially differ from management’s estimates. Our Company also considers that the events and factors described above continue to constitute impairment indicators under ASC 350 Intangibles – Goodwill and Other. Our Company performed a quantitative goodwill impairment test and determined that our goodwill was not impaired as of December 31, 2021. The test was performed at a reporting unit level by comparing each reporting unit’s carrying value, including goodwill, to its fair value. The fair value of each reporting unit was assessed using a discounted cash flow model based on the budgetary revisions performed by management in response to COVID-19 and the developing market conditions. Actual performance against our forecasts is dependent on several variables and conditions, many of which are subject to the uncertainties associated with COVID-19 and as a result, actual results may materially differ from management’s estimates.

Impact Of COVID-19 Pandemic On Liquidity

12 Months Ended

Dec. 31, 2021

Impact Of COVID-19 Pandemic On Liquidity [Abstract]

Impact Of COVID-19 Pandemic On Liquidity

NOTE 3 – IMPACT OF COVID-19 PANDEMIC ON LIQUIDITY GeneralOn March 11, 2020, the World Health Organization (“WHO”) declared the novel coronavirus, COVID-19, a global pandemic. In March 2020 we temporarily closed all of our live theatres and cinema operations in the U.S., Australia and New Zealand. Operating restrictions adopted in Australia and New Zealand also affected many of our tenants at our retail shopping centers. These closures materially negatively impacted our revenues and profitability. Our cinemas began reopening at various times throughout the last quarter of 2020 and into 2021. COVID-19 has progressed through several variants, with the most current variant affecting the jurisdictions in which we do business being the Omicron variant. Vaccination programs are advancing, and it appears that societies are moving towards relaxing restrictions. There can be no assurances, however, that the current trend of reduced restrictions will continue, nor that there will be no further variants of COVID-19 which could lead to material business disruption. During 2020, we successfully implemented our COVID-19 response plans, generating cash inflows from strategic asset monetizations of $179.1 million and reducing or refinancing key debt. As a result of this, and the increasing health of the cinema segment, we have concluded that our Company has sufficient resources to meet its obligations as they become due within one year after the issuance of this Form 10-K. Cinema Segment Ongoing ImpactAs of December 31, 2021, none of our cinemas are closed as a result of COVID-19 government closure orders. As of the date of this report, substantially all of our U.S. cinemas are trading. On March 3, 2022, we reopened our Consolidated Theatre in Kapolei following a renovation. All of our New Zealand cinemas are trading except Courtenay Central which continues to be closed due to non-COVID related seismic concerns which predated the pandemic. A return to operation of this center has been delayed, however, by among other things our efforts to respond to COVID-19. Our Australian circuit is fully open. Real Estate Segment Ongoing ImpactSubstantially all of our tenants in our Australian and New Zealand real estate businesses (excluding Courtenay Central) are currently open for trading. In the U.S., much of our real estate income has traditionally been generated by rental revenue from our live theatres. As of the date of this report, our Minetta and Orpheum theatres are conducting public performances. Liquidity ImpactThe continued disruption of our global cinemas caused by COVID-19 led to a significant decrease in our Company’s revenues and earnings for the year ended December 31, 2021, as compared to pre-COVID-19 operations. Such effects will likely continue, to varying degrees, until the virus is materially contained and its impact on the cinema going public abates. As compared to the year ended December 31, 2020, our revenues and earnings have increased as we have been able to reopen, and keep open, many of our cinemas. Even though we are encouraged by the return of patrons to our cinemas and theatres and the movie releases expected in the coming months, we cannot provide any assurances as to the nature or pace of a return to prior operating levels. With regards to our real estate operations, while all our New Zealand and Australian real estate tenants are currently trading (other than certain tenants who have closed for reasons unrelated to COVID-19), our real estate revenue and earnings may again be affected by any rent relief that we may deem necessary to provide to certain tenants experiencing continuing impacts from COVID-19. Going ConcernWe continue to evaluate the going concern assertion required by ASC 205-40 Going Concern as it relates to our Company. Management’s evaluation is informed by current liquidity positions, cash flow estimates, known capital and other expenditure requirements and commitments and management’s current business plan and strategies. Our Company’s business plan - two businesses (real estate and cinema) in three countries (Australia, New Zealand and the U.S.) - has served us well since the onset of COVID-19 and is key to management’s overall evaluation of ASC 205-40 Going Concern. The cumulative impact of COVID-19 on our cinema business led to the conclusion in the third quarter of 2020 that there was substantial doubt regarding our Company’s ability to continue as a going concern; however, management’s plans to alleviate such substantial doubt included the adoption of plans to refinance our 44 Union Square property and the monetization of certain real estate assets. By June 2021 we had successfully executed these plans, as detailed in Note 5 – Real Estate Transactions and Note 11 – Borrowings. The execution of these plans generated cash inflows of $179.1 million. Furthermore, we have reduced our debt from $282.6 million at December 31, 2020 to $234.0 million at December 31, 2021. We have no debt maturing until March 2023, being our Bank of America facility as presented at Note 11 - Borrowings, and we have the funds to repay this debt in the event that our refinancing efforts are unsuccessful. There have been no material business developments in the period since the execution of our plans that have negatively impacted our assessment of our going concern position. We acknowledge the impact of the Omicron variant on the cinema industry, but its impact is proving to be less than those of past variants. We believe that our current cash holdings, and the current and expected future improvements in the cinema industry, are such that our going concern assessment has not changed since the execution of management’s plans. Our current financial position, forecasts and cash flow estimates based on our current expectations of industry performance and recovery, mean that our Company has sufficient resources to meet its obligations as they become due within one year after the issuance of this report on Form 10-K. Our forecasts and cash flow estimates are based on the current expectation that the global cinema industry will continue to recover in 2022 and 2023. Forecasts are by their nature inherently uncertain, but the effects of COVID-19 continue to cause greater forecasting difficulties than would otherwise exist in more stable economic times. While we are seeing substantial evidence of recovery, our forecasts rely upon the ability and desire of moviegoers to return to the movie theatres. Many factors influencing this are outside of management’s control, but are, nevertheless, material, individually and in the aggregate, to the realization of management’s forecasts and expectations throughout the period of COVID-19. Impairment Considerations Our Company considers that the events and factors described above continue to constitute impairment indicators under ASC 360 Property, Plant and Equipment. At December 31, 2021, our Company performed a quantitative recoverability test of the carrying values of all its asset groups. Our Company estimated the undiscounted future cash flows expected to result from the use of these asset groups and found that no impairment charge was necessary. This was due to our improved financial performance at the asset group level, and our more favorable expectations for future trading. Actual performance against our forecasts is dependent on several variables and conditions, many of which are subject to the uncertainties associated with COVID-19 and as a result, actual results may materially differ from management’s estimates. Our Company also considers that the events and factors described above continue to constitute impairment indicators under ASC 350 Intangibles – Goodwill and Other. Our Company performed a quantitative goodwill impairment test and determined that our goodwill was not impaired as of December 31, 2021. The test was performed at a reporting unit level by comparing each reporting unit’s carrying value, including goodwill, to its fair value. The fair value of each reporting unit was assessed using a discounted cash flow model based on the budgetary revisions performed by management in response to COVID-19 and the developing market conditions. Actual performance against our forecasts is dependent on several variables and conditions, many of which are subject to the uncertainties associated with COVID-19 and as a result, actual results may materially differ from management’s estimates.